KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Gross Profit (2016 - 2025)

Thermo Fisher Scientific (TMO) has disclosed Gross Profit for 16 consecutive years, with $7.4 billion as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Gross Profit rose 0.92% year-over-year to $7.4 billion, compared with a TTM value of $29.2 billion through Sep 2024, down 2.53%, and an annual FY2023 reading of $29.7 billion, down 3.19% over the prior year.
  • Gross Profit was $7.4 billion for Q3 2024 at Thermo Fisher Scientific, roughly flat from $7.4 billion in the prior quarter.
  • Across five years, Gross Profit topped out at $13.5 billion in Q4 2020 and bottomed at $3.8 billion in Q4 2021.
  • Average Gross Profit over 5 years is $7.2 billion, with a median of $7.4 billion recorded in 2023.
  • Peak annual rise in Gross Profit hit 119.43% in 2021, while the deepest fall reached 71.8% in 2021.
  • Year by year, Gross Profit stood at $13.5 billion in 2020, then tumbled by 71.8% to $3.8 billion in 2021, then surged by 104.42% to $7.8 billion in 2022, then fell by 7.92% to $7.2 billion in 2023, then increased by 3.84% to $7.4 billion in 2024.
  • Business Quant data shows Gross Profit for TMO at $7.4 billion in Q3 2024, $7.4 billion in Q2 2024, and $7.1 billion in Q1 2024.